Therapy of newly diagnosed follicular lymphoma

por Westin, Jason R., Neelapu, Sattva S.
Publicado 2012

The race is on: bispecifics vs CAR T cells in B-cell lymphoma

por Gurumurthi, Ashwath, Westin, Jason, Subklewe, Marion
Publicado 2023

Hodgkin Lymphoma Untreated for Six Years Presenting with Tracheoesophageal Fistula

por Westin, Jason R., Gibbs, Amye, Mills, Keith R., Neelapu, Sattva S.
Publicado 2012

Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphoma

por Nowakowski, Grzegorz S., Feldman, Tatyana, Rimsza, Lisa M., Westin, Jason R., Witzig, Thomas E., Zinzani, Pier Luigi
Publicado 2019

Efficacy and safety of CD19‐directed CAR‐T cell therapies in patients with relapsed/refractory aggressive B‐cell lymphomas: Observations from the JULIET, ZUMA‐1, and TRANSCEND tria...

por Westin, Jason R., Kersten, Marie José, Salles, Gilles, Abramson, Jeremy S., Schuster, Stephen J., Locke, Frederick L., Andreadis, Charalambos
Publicado 2021

A Single Case of Rosai–Dorfman Disease Marked by Pathologic Fractures, Kidney Failure, and Liver Cirrhosis Treated with Single-Agent Cladribine

por Sasaki, Koji, Pemmaraju, Naveen, Westin, Jason R., Wang, Wei-Lien, Khoury, Joseph D., Podoloff, Donald A., Moon, Bryan, Daver, Naval, Borthakur, Gautam
Publicado 2014

Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis

por Chihara, Dai, Fowler, Nathan H., Oki, Yasuhiro, Fanale, Michelle A., Nastoupil, Loretta J., Westin, Jason R., Fayad, Luis E., Neelapu, Sattva S., Cheah, Chan Yoon
Publicado 2018

P1092: A PHASE II INVESTIGATOR INITIATED STUDY OF ACALABRUTINIB, LENALIDOMIDE AND RITUXIMAB (AR2) IN PATIENTS WITH PREVIOUSLY UNTREATED HIGH TUMOR BURDEN FOLLICULAR LYMPHOMA

por Strati, Paolo, Feng, Lei, Westin, Jason, Nair, Ranjit, Gouni, Sushanth, Fayad, Luis, Rodriguez, Maria, Chihara, Dai, Malpica, Luis, Steiner, Raphael, Gallardo, Mariana, Nastoupil, Loretta J., Neelapu, Sattva
Publicado 2023

Primary CNS lymphoma commonly expresses immune response biomarkers

por Ou, Alexander, Sumrall, Ashley, Phuphanich, Surasak, Spetzler, David, Gatalica, Zoran, Xiu, Joanne, Michelhaugh, Sharon, Brenner, Andrew, Pandey, Manjari, Kesari, Santosh, Korn, W Michael, Mittal, Sandeep, Westin, Jason, Heimberger, Amy B
Publicado 2020

Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions

por Pinnix, Chelsea C., Andraos, Therese Y., Dabaja, Bouthaina, Milgrom, Sarah, Smith, Grace, Chihara, Dai, Ng, Andrea, Fayad, Luis E., Oki, Yasuhiro, Neelapu, Sattva, Westin, Jason, Rodriguez, M. Alma, Nastoupil, Loretta J.
Publicado 2017

Steroid-Refractory Acute GVHD: Predictors and Outcomes

por Westin, Jason R., Saliba, Rima M., De Lima, Marcos, Alousi, Amin, Hosing, Chitra, Qazilbash, Muzaffar H., Khouri, Issa F., Shpall, Elizabeth J., Anderlini, Paolo, Rondon, Gabriela, Andersson, Borje S., Champlin, Richard, Couriel, Daniel R.
Publicado 2011

Preclinical efficacy and biological effects of the oral proteasome inhibitor ixazomib in diffuse large B-cell lymphoma

por Liu, Wei, Chen, Juan, Tamayo, Archito T., Ruan, Changgeng, Li, Li, Zhou, Shouhao, Shen, Chan, Young, Ken H., Westin, Jason, Davis, Richard E., Hu, Shimin, Medeiros, Leonard J., Ford, Richard J., Pham, Lan V.
Publicado 2017

Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden

por Liang, Winnie S., Vergilio, Jo‐Anne, Salhia, Bodour, Huang, Helen J., Oki, Yasuhiro, Garrido‐Laguna, Ignacio, Park, Haeseong, Westin, Jason R., Meric‐Bernstam, Funda, Fabrizio, David, Miller, Vincent A., Stephens, Philip J., Fanale, Michelle A., Ross, Jeffrey S., Janku, Filip
Publicado 2018

Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma

por Strati, Paolo, Ahmed, Mohamed Amin, Fowler, Nathan H., Nastoupil, Loretta J., Samaniego, Felipe, Fayad, Luis E., Hagemeister, Fredrick B., Romaguera, Jorge E., Rodriguez, Alma, Wang, Michael, Westin, Jason R., Cheah, Chan, Noorani, Mansoor, Feng, Lei, Davis, Richard E., Neelapu, Sattva S.
Publicado 2020

Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma

por Nastoupil, Loretta J., Chin, Collin K., Westin, Jason R., Fowler, Nathan H., Samaniego, Felipe, Cheng, Xiaoyun, Ma, Man Chun John, Wang, Zhiqiang, Chu, Fuliang, Dsouza, Ly, Obi, Chizobam, Mims, Jennifer, Feng, Lei, Zhou, Shouhao, Green, Michael, Davis, Richard Eric, Neelapu, Sattva S.
Publicado 2022

PD-L1(+) macrophages are associated with favorable features in primary mediastinal (thymic) large B-cell lymphoma

por Steiner, Raphael E., Parra, Edwin R., Vega, Francisco, Feng, Lei, Westin, Jason R., Neelapu, Sattva S., Strati, Paolo, Green, Michael R., Flowers, Christopher R., Solis, Luisa M., Wistuba, Ignacio I., Ahmed, Sairah, Nair, Ranjit, Hagemeister, Fredrick B., Noorani, Mansoor, Marques-Piubelli, Mario L.
Publicado 2023

Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study

por Olszewski, Adam J., Phillips, Tycel J., Hoffmann, Marc S., Armand, Philippe, Kim, Tae Min, Yoon, Dok Hyun, Mehta, Amitkumar, Greil, Richard, Westin, Jason, Lossos, Izidore S., Munoz, Javier L., Sit, Jason, Wei, Michael C., Yang, Annie, Chen, Vivian, Purev, Enkhtsetseg, Yee, Donald L., Jaeger, Ulrich
Publicado 2023

Lenalidomide plus rituximab (R(2)) in previously untreated marginal zone lymphoma: subgroup analysis and long‐term follow‐up of an open‐label phase 2 trial

por Becnel, Melody R., Nastoupil, Loretta J., Samaniego, Felipe, Davis, Richard E., You, M. J., Green, Michael, Hagemeister, Fredrick B., Fanale, Michelle A., Fayad, Luis E., Westin, Jason R., Wang, Michael, Oki, Yasuhiro, Forbes, Sheryl G., Feng, Lei, Neelapu, Sattva S., Fowler, Nathan H.
Publicado 2019

Day 30 SUV(max) predicts progression in patients with lymphoma achieving PR/SD after CAR T-cell therapy

por Al Zaki, Ajlan, Feng, Lei, Watson, Grace, Ahmed, Sairah A., Mistry, Haleigh, Nastoupil, Loretta J., Hawkins, Misha, Nair, Ranjit, Iyer, Swaminathan P., Lee, Hun J., Steiner, Raphael E., Flowers, Christopher R., Shpall, Elizabeth J., Kebriaei, Partow, Neelapu, Sattva S., Westin, Jason R., Strati, Paolo
Publicado 2022

Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma

por Steiner, Raphael E., Banchs, Jose, Koutroumpakis, Efstratios, Becnel, Melody, Gutierrez, Cristina, Strati, Paolo, Pinnix, Chelsea C., Feng, Lei, Rondon, Gabriela, Claussen, Catherine, Palaskas, Nicolas, Karimzad, Kaveh, Ahmed, Sairah, Neelapu, Sattva S., Shpall, Elizabeth, Wang, Michael, Vega, Francisco, Westin, Jason, Nastoupil, Loretta J., Deswal, Anita
Publicado 2021